These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22172787)

  • 1. Determinants of FDG uptake in atherosclerosis.
    Buettner C; Rudd JH; Fayad ZA
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1302-4. PubMed ID: 22172787
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.
    Cocker MS; Mc Ardle B; Spence JD; Lum C; Hammond RR; Ongaro DC; McDonald MA; Dekemp RA; Tardif JC; Beanlands RS
    J Nucl Cardiol; 2012 Dec; 19(6):1211-25. PubMed ID: 23073913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of FDG PET/CT in investigating the mechanisms underlying atherosclerotic plaque formation and evolution.
    Marzola MC; Saboury B; Chondrogiannis S; Rampin L; Grassetto G; Ferretti A; Alavi A; Rubello D
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):246-52. PubMed ID: 23726249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; Sánchez-González J; Macías A; Pérez-Asenjo B; Zamudio D; Alonso-Farto JC; España S; Mendiguren J; Bueno H; García-Ruiz JM; Ibañez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2019 Apr; 73(12):1371-1382. PubMed ID: 30922468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
    J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors.
    Reijrink M; de Boer SA; Spoor DS; Lefrandt JD; Lambers Heerspink HJ; Boellaard R; Greuter MJ; Borra RJH; Hillebrands JL; Slart RHJA; Mulder DJ
    Atherosclerosis; 2019 Nov; 290():87-93. PubMed ID: 31604171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease.
    Stolzmann P; Subramanian S; Abdelbaky A; Maurovich-Horvat P; Scheffel H; Tawakol A; Hoffmann U
    Radiographics; 2011; 31(5):1255-69. PubMed ID: 21918043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence.
    Marnane M; Merwick A; Sheehan OC; Hannon N; Foran P; Grant T; Dolan E; Moroney J; Murphy S; O'Rourke K; O'Malley K; O'Donohoe M; McDonnell C; Noone I; Barry M; Crowe M; Kavanagh E; O'Connell M; Kelly PJ
    Ann Neurol; 2012 May; 71(5):709-18. PubMed ID: 22461139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.
    Figueroa AL; Subramanian SS; Cury RC; Truong QA; Gardecki JA; Tearney GJ; Hoffmann U; Brady TJ; Tawakol A
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):69-77. PubMed ID: 22038986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Multiparametric Evaluation of Experimental Atherosclerosis in Rabbits.
    Senders ML; Lobatto ME; Soler R; Lairez O; Pérez-Medina C; Calcagno C; Fayad ZA; Mulder WJM; Fay F
    Methods Mol Biol; 2018; 1816():385-400. PubMed ID: 29987836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo ¹⁸F-FDG-PET Imaging in Mouse Atherosclerosis.
    Mateo J; Bilbao I; Vaquero JJ; Ruiz-Cabello J; España S
    Methods Mol Biol; 2015; 1339():377-86. PubMed ID: 26445805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
    Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
    Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
    Calcagno C; Lairez O; Hawkins J; Kerr SW; Dugas MS; Simpson T; Epskamp J; Robson PM; Eldib M; Bander I; K-Raman P; Ramachandran S; Pruzan A; Kaufman A; Mani V; Ehlgen A; Niessen HG; Broadwater J; Fayad ZA
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):291-301. PubMed ID: 29413439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis imaging using PET: Insights and applications.
    Sriranjan RS; Tarkin JM; Evans NR; Le EPV; Chowdhury MM; Rudd JHF
    Br J Pharmacol; 2021 Jun; 178(11):2186-2203. PubMed ID: 31517992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.